Literature DB >> 30445355

Altered profiles and metabolism of l- and d-amino acids in cultured human breast cancer cells vs. non-tumorigenic human breast epithelial cells.

Siqi Du1, Yadi Wang1, Nagham Alatrash1, Choyce A Weatherly1, Daipayan Roy1, Frederick M MacDonnell1, Daniel W Armstrong2.   

Abstract

Herein we describe for the first time the endogenous levels of free l-and d-amino acids in cultured human breast cancer cells (MCF-7) and non-tumorigenic human breast epithelial cells (MCF-10A). d-Asp and d-Ser, which are co-agonists of the N-methyl-d-aspartate (NMDA) receptors, showed significantly elevated levels in MCF-7 cancer cells compared to MCF-10A cells. This may result from upregulated enzymatic racemases. Possible roles of these d-amino acids in promoting breast cancer proliferation by regulating NMDA receptors were indicated. d-Asn may also be able to serve as exchange currency, like specific l-amino acids, for the required uptake of essential amino acids and other low abundance nonessential amino acids which were elevated nearly 60 fold in cancer cells. The relative levels of specific l- and d-amino acids can be used as malignancy indicators (MIs) for the breast cancer cell line in this study. High MIs (>50) result from the increased demands of specific essential amino acids. Very low MIs (<1) result from the increased demands of specific d-amino acids (i.e., d-Ser, d-Asp) or the cellular release of amino acid exchange currency (i.e., l- and d-Asn) used in the upregulated amino acid antiporters to promote cancer cell proliferation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer; Exchange currency; Malignancy indicator; NMDA receptor; Oncometabolites; l- and d-amino acids

Mesh:

Substances:

Year:  2018        PMID: 30445355     DOI: 10.1016/j.jpba.2018.10.047

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  7 in total

1.  Evaluation of Untargeted Metabolomic Strategy for the Discovery of Biomarker of Breast Cancer.

Authors:  Xujun Ruan; Yan Wang; Lirong Zhou; Qiuling Zheng; Haiping Hao; Dandan He
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

Review 2.  Indirect Enantioseparations: Recent Advances in Chiral Metabolomics for Biomedical Research.

Authors:  Luisa-Gabriela Bogos; Ioana-Ecaterina Pralea; Radu-Cristian Moldovan; Cristina-Adela Iuga
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

3.  Roles of N-methyl-D-aspartate receptors and D-amino acids in cancer cell viability.

Authors:  Siqi Du; Yu-Sheng Sung; Michael Wey; Yadi Wang; Nagham Alatrash; Alain Berthod; Frederick M MacDonnell; Daniel W Armstrong
Journal:  Mol Biol Rep       Date:  2020-09-05       Impact factor: 2.316

Review 4.  D-Amino Acids and D-Amino Acid-Containing Peptides: Potential Disease Biomarkers and Therapeutic Targets?

Authors:  Mohamed Abdulbagi; Liya Wang; Orwa Siddig; Bin Di; Bo Li
Journal:  Biomolecules       Date:  2021-11-18

Review 5.  Metabolomics of Breast Cancer: A Review.

Authors:  Ramadevi Subramani; Seeta Poudel; Kenneth D Smith; Adriana Estrada; Rajkumar Lakshmanaswamy
Journal:  Metabolites       Date:  2022-07-13

6.  Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide.

Authors:  Alessia Lodi; Renu Pandey; Jennifer Chiou; Ayon Bhattacharya; Shiliang Huang; Xingxin Pan; Brandon Burgman; S Stephen Yi; Stefano Tiziani; Andrew J Brenner
Journal:  Front Oncol       Date:  2022-09-26       Impact factor: 5.738

Review 7.  d-amino Acids in Health and Disease: A Focus on Cancer.

Authors:  Jacco J A J Bastings; Hans M van Eijk; Steven W Olde Damink; Sander S Rensen
Journal:  Nutrients       Date:  2019-09-12       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.